Everest Organics Ltd Hits New 52-Week High at Rs.513.8

3 hours ago
share
Share Via
Everest Organics Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 30 Dec 2025 by hitting a new 52-week and all-time high of Rs.513.8. This marks a remarkable rally for the stock, reflecting strong momentum over the past year.



Stock Performance and Market Context


On the day the new high was recorded, Everest Organics opened with a gap up, gaining 2.25% from the previous close. The stock touched an intraday high of Rs.513.8, setting the fresh peak, before closing with a day change of -2.86%. Despite this slight pullback, the stock remains well above its key moving averages, trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling sustained upward momentum.


In comparison, the broader Sensex index opened lower by 94.55 points and was trading at 84,600.50, down 0.11% on the same day. The Sensex remains 1.84% below its own 52-week high of 86,159.02, highlighting Everest Organics’ outperformance relative to the benchmark. Over the past year, Everest Organics has delivered a robust return of 58.93%, significantly outpacing the Sensex’s 8.12% gain.



Price Range and Volatility


The stock’s 52-week low stands at Rs.210.95, underscoring the substantial appreciation in value over the last twelve months. The intraday price range on the day of the new high was between Rs.488 and Rs.513.8, reflecting some volatility but overall positive price action. The stock’s ability to sustain levels above multiple moving averages further confirms the strength of the rally.




Just made the cut! This Mid Cap from the Heavy Electrical Equipment sector entered our elite Top 1% list recently. Discover it before the crowd catches on!



  • - Top-rated across platform

  • - Strong price momentum

  • - Near-term growth potential


Discover the Stock Now →




Mojo Score and Rating Upgrade


Everest Organics currently holds a Mojo Score of 57.0, categorised as a Hold rating. This represents an upgrade from its previous Sell rating, which was revised on 20 Jun 2025. The stock’s Market Cap Grade is 4, indicating a mid-tier market capitalisation within its sector. The rating upgrade reflects improved fundamentals and price momentum, aligning with the stock’s recent performance and technical strength.



Sector and Industry Positioning


Operating within the Pharmaceuticals & Biotechnology sector, Everest Organics has demonstrated resilience and growth amid a competitive landscape. The sector itself has experienced mixed performance, with some stocks facing headwinds, but Everest Organics’ price appreciation and technical indicators suggest it has capitalised on favourable market conditions. The stock’s outperformance relative to the sector and benchmark indices highlights its distinct momentum.



Technical Indicators and Moving Averages


The stock’s position above all key moving averages is a notable technical achievement. Trading above the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages typically signals a strong bullish trend and investor confidence in the stock’s trajectory. This technical alignment supports the sustainability of the recent rally and the new 52-week high.




Everest Organics Ltd or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!



  • - SwitchER analysis complete

  • - Superior alternatives found

  • - Multi-parameter evaluation


See Smarter Alternatives →




Intraday Price Movement and Market Reaction


Despite the stock’s new high, the day’s trading saw some profit-taking, with the price retreating from the intraday peak of Rs.513.8 to close lower by 2.86%. The intraday low was Rs.488, indicating a price range of approximately 5% on the day. This volatility is not uncommon following a significant price milestone, as market participants reassess valuations and lock in gains.



Comparative Analysis with Sensex


While Everest Organics surged to a new high, the Sensex index showed a modest decline on the same day. The index’s trading below its 50-day moving average, despite the 50DMA being above the 200DMA, suggests a cautious market environment. Everest Organics’ ability to buck this trend and achieve a fresh peak underscores its relative strength within the broader market context.



Summary of Key Metrics


To summarise, Everest Organics Ltd’s key metrics as of 30 Dec 2025 are:



  • New 52-week and all-time high price: Rs.513.8

  • Day’s high: Rs.513.8 (2.25% gain at open)

  • Day’s low: Rs.488 (-2.89%)

  • Day change: -2.86%

  • 1-year price appreciation: 58.93%

  • Sensex 1-year gain: 8.12%

  • Mojo Score: 57.0 (Hold rating, upgraded from Sell on 20 Jun 2025)

  • Market Cap Grade: 4



The stock’s performance over the past year, combined with its technical positioning and rating upgrade, marks a significant achievement for Everest Organics Ltd in the Pharmaceuticals & Biotechnology sector.



Conclusion


Everest Organics Ltd’s attainment of a new 52-week high at Rs.513.8 represents a noteworthy milestone, reflecting strong price momentum and improved market perception. The stock’s sustained trading above key moving averages and its outperformance relative to the Sensex highlight its robust position within the sector. While the day’s trading showed some volatility, the overall trend remains positive, underscoring the stock’s resilience and growth over the past year.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News